Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuji Koike

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Cancer Science|June 27, 2023
Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritisKeisuke Tanaka, Ayako Ichikawa, Natsuka Umezawa, et al.
British Journal of Haematology|May 11, 2026
Clinical features and prognostic factors of adult systemic chronic active EBV disease: A retrospective analysis in JapanAika Fuseya, Masahide Yamamoto, Miwako Nishio, et al.
BMC Infectious Diseases|August 31, 2021
Three-day regimen of oseltamivir for post-exposure prophylaxis of influenza in hospital wards: a study protocol for a prospective, multi-center, single-arm trialNobuhisa Ishiguro, Yoichi M Ito, Sumio Iwasaki, et al.
NAR Genomics and Bioinformatics|November 2, 2023
Estimating gene-level false discovery probability improves eQTL statistical fine-mapping precisionQingbo S Wang, Ryuya Edahiro, Ho Namkoong, et al.
The Lancet Regional Health. Western Pacific|August 9, 2023
Safety, efficacy and pharmacokinetics of palivizumab in off-label neonates, infants, and young children at risk for serious respiratory syncytial virus infection: a multicenter phase II clinical trialMasaaki Mori, Kanako Yoshizaki, Shinichi Watabe, et al.
Frontiers in Immunology|November 1, 2023
Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matchingSeiya Oba, Tadashi Hosoya, Risa Kaneshige, et al.
BMC Pediatrics|January 28, 2019
Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocolMasatoshi Takagi, Chitose Ogawa, Yuki Aoki-Nogami, et al.
Modern Rheumatology|November 17, 2016
Simplified Disease Activity Index remission at month 6 is an independent predictor of functional and structural remissions at month 12 during abatacept treatment in patients with rheumatoid arthritis: A multi-center, prospective cohort study in JapanHayato Yamazaki, Fumio Hirano, Tsutomu Takeuchi, et al.
Pulmonary Pharmacology & Therapeutics|February 9, 2011
Tacrolimus-induced pulmonary injury in rheumatoid arthritis patientsRyuji Koike, Michi Tanaka, Yukiko Komano, et al.
Rheumatology International|May 24, 2014
The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) databaseRyoko Sakai, Soo-Kyung Cho, Toshihiro Nanki, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Cancer Science|June 27, 2023
Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritisKeisuke Tanaka, Ayako Ichikawa, Natsuka Umezawa, et al.
British Journal of Haematology|May 11, 2026
Clinical features and prognostic factors of adult systemic chronic active EBV disease: A retrospective analysis in JapanAika Fuseya, Masahide Yamamoto, Miwako Nishio, et al.
BMC Infectious Diseases|August 31, 2021
Three-day regimen of oseltamivir for post-exposure prophylaxis of influenza in hospital wards: a study protocol for a prospective, multi-center, single-arm trialNobuhisa Ishiguro, Yoichi M Ito, Sumio Iwasaki, et al.
NAR Genomics and Bioinformatics|November 2, 2023
Estimating gene-level false discovery probability improves eQTL statistical fine-mapping precisionQingbo S Wang, Ryuya Edahiro, Ho Namkoong, et al.
The Lancet Regional Health. Western Pacific|August 9, 2023
Safety, efficacy and pharmacokinetics of palivizumab in off-label neonates, infants, and young children at risk for serious respiratory syncytial virus infection: a multicenter phase II clinical trialMasaaki Mori, Kanako Yoshizaki, Shinichi Watabe, et al.
Frontiers in Immunology|November 1, 2023
Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matchingSeiya Oba, Tadashi Hosoya, Risa Kaneshige, et al.
BMC Pediatrics|January 28, 2019
Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocolMasatoshi Takagi, Chitose Ogawa, Yuki Aoki-Nogami, et al.
Modern Rheumatology|November 17, 2016
Simplified Disease Activity Index remission at month 6 is an independent predictor of functional and structural remissions at month 12 during abatacept treatment in patients with rheumatoid arthritis: A multi-center, prospective cohort study in JapanHayato Yamazaki, Fumio Hirano, Tsutomu Takeuchi, et al.
Pulmonary Pharmacology & Therapeutics|February 9, 2011
Tacrolimus-induced pulmonary injury in rheumatoid arthritis patientsRyuji Koike, Michi Tanaka, Yukiko Komano, et al.
Rheumatology International|May 24, 2014
The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) databaseRyoko Sakai, Soo-Kyung Cho, Toshihiro Nanki, et al.
Pageof 11